Wednesday, June 22, 2011

Research: Prostate cancer deaths mostly down to cancer

Recent research has revealed that the majority of deaths from prostate cancer are due to the cancer itself.

The team from King's College London looked at 50,667 men with prostate cancer over the course of a decade.

Over this time period a total of 20,181 men died. Of these, 49 per cent died as a result of the cancer itself.

Around 12 per cent died due to other cancers, 17 per cent died because of heart disease, eight per cent from pneumonia and 13 per cent due to other causes.

Professor Henrik Moller, study author from King's College London and head of analysis and research at the NCIN, said: "Our data show that a high proportion of men with prostate cancer die from the cancer.

"Our findings challenge the commonly held view that most men with prostate cancer will die with the disease rather than from it."

Recommendations on Cell Phone Use and Cancer Risk

The evidence is limited when it comes to cell phones and cancer risk, but specialists say common-sense measures can come into play until the science catches up with technology.

The issue is back in the news after the World Health Organization's recent announcement that cell phone use should be considered "possibly carcinogenic." There are an estimated 5 billion mobile phones in use around the world.

The working group from the organization's International Agency for Research on Cancer was careful not to make any firm conclusions.

"The evidence, while still accumulating, is strong enough to support a conclusion and the 2B classification," reported Working Group Chair Jonathan Samet, MD, from the University of Southern California in Los Angeles. This category is used for agents when there is limited evidence.

Others have suggested a cancer risk before, but the organization's consortium is the most significant to classify the radiation emitted by cell phones in this way.

Still, the group, which consists of 31 scientists from 14 countries, avoided calling cell phones carcinogenic and passed on classifying them even as probably cancer causing.

This has left some practicing clinicians shaking their heads in annoyance as cancer fears ripple through the community.

"The classification the working group selected is very weak, and I think people are now focusing too much on the possibly carcinogenic part," neuro-oncologist Lynne Taylor, MD, from Virginia Mason Medical Center in Seattle, Washington, said in an interview.

Dr. Taylor says she agrees that more research is necessary, but this won't affect how she uses her cell phone or counsels patients. "This is not anything to worry about," she said.

"I think that any problems reflect the subtlety of 'possible,' which by no means indicates an established carcinogen," Dr. Samet told Medscape Medical News. Despite some misunderstanding, he added, "many have interpreted the statement correctly."

However, Dr. Samet acknowledged, "anyone concerned about risk can take steps to reduce exposure by using a hands-free device or texting. Additionally, current phones have lower outputs than the older phones that were investigated in the epidemiological studies."

The Lancet Oncology is scheduled to publish the World Health Organization's full working group report in their July 1 print issue.

Several major agencies moved quickly to respond to these new conclusions that have been widely reported in the consumer press. In a statement, the National Cancer Institute pointed out, "This is neither new research nor at odds with previous findings."

The institute acknowledged it agrees with the working group that continued monitoring of both brain cancer trends and new evidence from studies is called for.

However, they point out that Interphone, "considered the major study on cell phone use and cancer risk, has reported that overall, cell phone users have no increased risk of the most common forms of brain tumors — glioma and meningioma." The study showed no increased risk associated with progressively increasing number of calls, longer call time, or years since beginning cell phone use, the statement notes. "For the small proportion of study participants who reported spending the most total time on cell phone calls, there was some increased risk of glioma, but the researchers considered this finding inconclusive."

The National Toxicology Program at the National Institute of Environmental Health Sciences is currently leading the largest laboratory rodent study to date on cell phone radiofrequency exposures and potential health hazards, the institute statement adds. "The studies are designed to mimic human exposure and are based on the frequencies and modulations currently in use in the United States."

The American Cancer Society has also weighed in. "This report comes from a very credible group and reaches reasonable conclusions about electromagnetic radiation from cell phones and other devices," Chief Medical Officer Otis Brawley, MD, said in a statement.

"It is critical that its findings be interpreted with great care," he cautions. "The working group reviewed a large number of studies and concluded that there was limited evidence that cell phones may cause glioma." The bottom line, Dr. Brawley said, "is the evidence is enough to warrant concern, but it is not conclusive."

Radiofrequency Exposure

The fear is that radiofrequency electromagnetic fields produced by cell phones may affect the brain and other tissues because handheld devices are usually held close to the head. Researchers are looking at whether radiofrequency energy can cause malignant brain tumors, such as gliomas, as well as benign tumors, including acoustic neuromas and meningiomas.

The concern does not extend to cordless phones. Commonly used in homes, these devices have base units that are plugged into phone jacks that are wired to a local telephone service and operate at about 1/600 the power of cell phones.

The US Food and Drug Administration and the Federal Communications Commission have not linked cell phone use to cancer risk but have long recommended steps that cell phone users can take if they are concerned:

    * Reserve cell phone use for shorter conversations or for times when a land line is not available; and
    * Use a hands-free device that will place more distance between the mobile phone and the brain.

A cell phone user's level of exposure to radiofrequency depends on several factors, including the number and duration of calls, the amount of cell phone traffic at a given time, the distance from the nearest cellular base station, the quality of the cellular transmission, the size of the handset, and, for older phones, how far the antenna is extended.

In a recent study published in the Journal of the American Medical Association, investigators found that using a cell phone for as little as 50 minutes at a time appears to affect brain glucose metabolism in the region closest to the phone's antenna.

The researchers used positron emission tomography during cell phone use in the on and then off positions and found that although whole-brain metabolism was not affected, metabolism was increased in the orbitofrontal cortex and the temporal pole areas of the brain while the cell phone was on — areas close to where the phone's antenna meets the head.

However, the researchers, with lead author Nora Volkow, MD, from the National Institute on Drug Abuse in Bethesda, Maryland, acknowledge that it's not clear at this point whether this increase in metabolism is a good or bad thing. Increasing glucose metabolism could potentially have a positive effect in certain therapeutic situations.

Still, like Dr. Samet, Dr. Volkow recommends that cell phone users wanting to play it safe consider hands-free devices or speaker-phone mode to avoid direct contact of the cell phone with the head.

Worse for Children?

According to the National Cancer Institute and the American Cancer Society, there are currently no data on cell phone use and cancer risk in children. Even though cell phone use by children and adolescents is rising rapidly, no published studies to date have included young people.

Children may be at greater risk because their nervous systems are still developing. A large case-control study of childhood brain cancer in several Northern European countries is now under way.

Researchers from the Centre for Research in Environmental Epidemiology in Spain are conducting an international study known as Mobi-Kids to evaluate risk from new communications technologies and other environmental factors in young people ages 10 to 24 years.

There is no consensus among physicians and scientists about the severity of risk, or even if one exists. One of the many hurdles in evaluating a potential connection between cancer and cell phone use is the relatively short period these devices have been heavily used in a large population and the long latency period for many tumors.

Dr. Taylor says that for younger patients taking precautions makes sense. "Most teenagers are texting, and that's probably the most appropriate use for mobile phones. It's the people from my generation who are more likely to be pressing their cells against their ears. With teens, the focus of my attention will be to remind them not to text and drive or use their cell phone at all in the car."

She adds it probably isn't appropriate for very small children to be using cell phones anyway. "So that solves that."

While the evidence remains uncertain, Dr. Brawley added, it is up to each individual to determine what changes they wish to make after weighing the potential benefits and risks of using a cell phone.

"Limiting use among children also seems reasonable in light of this uncertainty. On the other hand, if someone is of the opinion that the absence of strong scientific evidence on the harms of cell phone use is reassuring, they may take different actions, and it would be hard to criticize that."

Rural doctors push bowel cancer message

RURAL doctors are urging more rural Australians to undertake a painless, at-home bowel cancer test to help reduce deaths by cancer.
The call follows recent Cancer Council research which shows that although more than 80% of people aged 50 and over are aware of the simple, at-home screening test for bowel cancer, less than half of those aware of the faecal occult blood test (FOBT) have actually done the test.

Dr Peter Rischbieth, Vice President of the Rural Doctors Association of Australia (RDAA), said the research again highlights the importance of early testing.

“The Cancer Council’s figures on death rates from bowel cancer continue to be really worrying—it is the nation’s second biggest cancer killer after lung cancer.

“Of all rural deaths, around one-third are caused by various types of cancer.

“Cancer sufferers in the bush have poorer survival rates than those in major metropolitan centres, and the further from a city you are, the more likely you are to die within five years of diagnosis, depending on the type of cancer you have.

“Thegood news is that 90% of bowel cancer cases can be cured if found early, so it is important that people over 50 take advantage of the FOBT—you can get it from the chemist, and it is free for those turning 50, 55 and 65.

“Some aspects of rural jobs like farming and mining are considered quite dangerous and there are all sorts of OH&S regulations to help save lives.

“But just as you shouldn’t drive a tractor without a roll-bar, you shouldn’t miss your FOBT once you reach the age of 50.”

The Cancer Council, National Health and Medical Research Council and Royal Australian College of General Practitioners recommend that those without symptoms or a family history of bowel cancer screen with an FOBT at least every two years from the age of 50.

“If you aren’t sure what it is all about, talk to your GP about it the next time you have an appointment. FOBT can pick up bowel cancer very early, so it isimportant that all rural Australians from 50 years on take advantage of this important and painless test” Dr Rischbieth said.

Alford family gives $1 million to James Cancer Hospital

A Newark woman and her brother have pledged $1 million to Ohio State University’s Arthur G. James Cancer Hospital and Richard J. Solove Research Institute to advance research in head and neck cancer.
Barb Cantlin and her husband, Mike, of Newark, joined her brother Ron Alford, of Westerville, in promising $1 million to the hospital over the next four years to create an endowed chair in head and neck cancer research, according to a news release from the hospital.

The $1 million donation adds to an original $500,000 donation made by Cantlin and Alford’s father, John Alford, in 1990, according to the release.
A former executive at Park National Bank, John Alford raised his family in Newark. When his wife, Mary, died of stomach cancer, he created an endowment fund for cancer research.
When John Alford died of esophageal cancer in 1996, his children donated an additional $500,000 to create the Mary E. and John W. Alford Cancer Research Endowment Fund, according to the release.
With the additional $1 million pledge, the fund will be renamed The Mary E. and John W. Alford Research Chair in Head and Neck Cancer once it reaches $2 million.
Part of the funding will come from the Alford Foundation, which is run by Ron and Cantlin and primarily supports organizations in Licking County, according to the release.
“We look at this gift as a tribute to our parents, and we are proud that the gift will support cancer research at The James,” Cantlin said in the release. “We always try to give back to Licking County, and there is a clear connection with this gift. We know that plenty of people in Licking County have benefited from The James. Daddy always taught us to give back.”